Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Pharm Des. 2004;10(18):2177-83.

Cannabinoids as neuroprotective agents in traumatic brain injury.

Author information

  • 1Department Functional Imaging, Lawrence Berkeley National Laboratory, Berkeley, CA, USA. BIEGON@BNL.GOV

Abstract

The name Cannabinoid applies to a large and diverse family of compounds including plant derived, synthetic and endogenously produced chemicals, some but not all of which are psychotropic. Cannabinoids of all classes have the ability to protect neurons from a variety of insults that are believed to underlie delayed neuronal death after traumatic brain injury (TBI), including excitotoxicity, calcium influx, free radical formation and neuroinflammation. The pathways and experimental models supporting a neuroprotective role for the various classes of cannabinoids are critically reviewed vis a vis their potential to support the development of a clinically viable neuroprotective agent for human TBI.

PMID:
15281893
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Bentham Science Publishers Ltd.
    Loading ...
    Support Center